why choose us

First received: August 03, 2023

Clinical Trial: Phase I/II Study of SKG0106 Intraocular Solution in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Neovascular Age-related Macular Degeneration

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Open-label, Dose Escalation, Phase 1 Clinical Study and Randomized, Double-masked, Controlled, Dose Expansion Phase 2 Clinical Study to Evaluate the Safety, Preliminary Efficacy, Immuno

Brief Summary: This is a phase 1/2 clinical study to evaluate the safety, preliminary efficacy, immunogenicity, and pharmacokinetic (PK) characteristics of SKG0106 in subjects with nAMD.Based on results from the phase 1 dose escalation study, the phase 2 expansion study will be conducted.

Read more